Values as of: 2025-03-11
COMMON STOCK | Healthcare Plans |
Last Closing
USD 422.04Change
+12.49 (+3.05)%Market Cap
USD 93.09BVolume
3.15MAnalyst Target
N/AVerdict
Verdict
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Company Website : https://www.elevancehealth.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| UNH | UnitedHealth Group Incorporate.. |
+5.82 (+1.21%) |
USD 481.78B |
| CNC | Centene Corp |
-0.87 (-1.46%) |
USD 28.20B |
| MOH | Molina Healthcare Inc |
-8.46 (-2.54%) |
USD 15.11B |
| OSCR | Oscar Health Inc |
-0.88 (-5.67%) |
USD 3.66B |
| NEUE | NeueHealth Inc |
+0.03 (+0.43%) |
USD 0.06B |
| CI | Cigna Corp |
-8.81 (-2.70%) |
N/A |
| CVS | CVS Health Corp |
-0.25 (-0.38%) |
N/A |
| HUM | Humana Inc |
-1.05 (-0.42%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| CAMX | Cambiar Aggressive Value .. | 5.75 % | 0.00 % |
-0.34 (-1.58%) |
USD 0.06B |
| FHI:CA | CI Health Care Giants Cov.. | 5.14 % | 0.75 % |
-0.18 (-1.58%) |
CAD 0.10B |
| ZWHC:CA | BMO Covered Call Health C.. | 4.88 % | 0.00 % |
-0.61 (-1.58%) |
N/A |
| WHCS:SW | iShares MSCI World Health.. | 3.67 % | 0.00 % |
N/A |
N/A |
| CBUF:F | iShares V Public Limited .. | 3.37 % | 0.00 % |
N/A |
N/A |
| AILV | 3.21 % | 0.00 % |
N/A |
N/A | |
| WELG:XETRA | Amundi S&P Global Health .. | 2.53 % | 0.00 % |
-0.36 (-1.58%) |
N/A |
| WELS:XETRA | Amundi S&P Global Health .. | 2.53 % | 0.00 % |
-0.38 (-1.58%) |
N/A |
| H41D:XETRA | HSBC MSCI World Value ESG.. | 2.16 % | 0.00 % |
-0.49 (-1.58%) |
N/A |
| ESGI:AU | VanEck MSCI International.. | 1.96 % | 0.00 % |
-0.46 (-1.58%) |
USD 0.19B |
| TEQI | T. Rowe Price Equity Inco.. | 1.82 % | 0.00 % |
-0.36 (-1.58%) |
USD 0.30B |
| PAPI | Morgan Stanley ETF Trust | 0.65 % | 0.00 % |
-0.42 (-1.58%) |
USD 0.14B |
| IHF | iShares U.S. Healthcare P.. | 0.00 % | 0.43 % |
-0.08 (-1.58%) |
N/A |
| HHL-U:CA | Harvest Healthcare Leader.. | 0.00 % | 0.00 % |
-0.08 (-1.58%) |
N/A |
| FHI-B:CA | CI Health Care Giants Cov.. | 0.00 % | 0.00 % |
N/A |
CAD 0.05B |
| RYH | 0.00 % | 0.40 % |
N/A |
N/A | |
| PBI-B:CA | Purpose Fund Corp. - Purp.. | 0.00 % | 0.00 % |
-0.05 (-1.58%) |
N/A |
| CBUF:XETRA | iShares MSCI World Health.. | 0.00 % | 0.00 % |
-0.19 (-1.58%) |
N/A |
| HHL-B:CA | Harvest Healthcare Leader.. | 0.00 % | 0.00 % |
-0.13 (-1.58%) |
N/A |
| Market Performance vs. Industry/Classification (Healthcare Plans) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 14.40% | 78% | C+ | 94% | A | ||
| Dividend Return | 0.46% | 50% | F | 25% | F | ||
| Total Return | 14.87% | 78% | C+ | 94% | A | ||
| Trailing 12 Months | |||||||
| Capital Gain | -16.52% | 44% | F | 17% | F | ||
| Dividend Return | 1.31% | 40% | F | 23% | F | ||
| Total Return | -15.22% | 44% | F | 16% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -0.21% | 33% | F | 30% | F | ||
| Dividend Return | 0.43% | 33% | F | 23% | F | ||
| Total Return | 0.64% | 20% | F | 16% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 11.14% | 89% | A- | 76% | C+ | ||
| Risk Adjusted Return | 3.89% | 44% | F | 23% | F | ||
| Market Capitalization | 93.09B | 83% | B | 98% | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
This stock has shown below median revenue growth in the previous 5 years compared to its sector
